OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS

Mergers & Acquisitions

Past Charts

M&A Transactions

M&A Transaction Chart

Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.

Week ended 06/02/2023

Week ended 06/02/2023

This Section is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.

M&A Transactions Commentary

Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.

Week ended 06/02/2023

The Largest M&A Deal of the Week:

  • On May 30, 2023, Agra Ventures (AGRA: CSE)(AGFAF: OTCPK) CQX) disclosed that it had acquired 100% of the issued and outstanding shares of AgraFlora Europe GmbH, parent of Farmako GmbH, a leading European medical cannabis distribution headquartered in Frankfurt Germany with affiliated companies in the United Kingdom.
    • Terms of the acquisition were not disclosed.
    • The acquisition gives AGRA cannabis distribution infrastructure, supply and licenses/ certifications, and experienced European cannabis operators.
    • AgraFlora-Farmako is meant to function as a European distribution hub for Agra Ventures’ medical cannabis.

Week ended 06/02/2023

This is the MA basic

Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.